Geriatric heart diseases in dogs.
A discussion of the diagnosis and therapy of heart disease in an aged pet does not differ significantly from that in a pet of any age. Mitral regurgitation constitutes by far the most important geriatric heart disease, and the selection of drugs to treat heart disease of aging pets is based on identification of specific pathologic features (eg, atrial fibrillation, left atrial enlargement) for which each aspect of treatment (eg, diuretics, angiotensin-converting enzyme inhibitors, spironolactone) is specific.
Hamlin
Robert L
RL
Department of Veterinary Biosciences, The Ohio State University College of Veterinary Medicine, 1920 Coffey Road, Columbus, OH 43210, USA. hamlin.1@osu.edu
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000375:Aging / Q000473:pathology* / Q000502:physiology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D004232:Diuretics / Q000627:therapeutic use; D004283:Dog Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D004285:Dogs; D004452:Echocardiography / Q000662:veterinary; D004562:Electrocardiography / Q000662:veterinary; D006331:Heart Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000662:veterinary*; D008944:Mitral Valve Insufficiency / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000662:veterinary; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D014665:Vasodilator Agents